NCT02431364View on ClinicalTrials.gov

Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults

PHASE1TerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 26, 2015

Primary Completion Date

October 1, 2015

Study Completion Date

October 1, 2015

Conditions
Healthy
Interventions
DRUG

Verdinexor

Participants received verdinexor; Dosage form: coated, immediate release Tablet; Route of administration: oral

OTHER

Placebo

Participants received placebo matched to verdinexor; Dosage form: coated, immediate release Tablet; Route of administration: oral

Trial Locations (1)

Unknown

Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
lead

Karyopharm Therapeutics Inc

INDUSTRY